Get started
Work

Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists

Year: 2019
Type: article
DOI: 10.1016/j.jacc.2019.01.029
Authors: Muthiah Vaduganathan, Ravi B. Patel, Avinainder Singh, Cian P. McCarthy, Arman Qamar, James L. Januzzi, Benjamin M. Scirica, Javed Butler, Christopher P. Cannon, Deepak L. Bhatt
Language: English
Field: Medicine
Open Access status: bronze
Funders: American Heart Association, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, Biogen, Alnylam Pharmaceuticals, Harvard Catalyst, Cleveland Clinic, Boston Scientific Corporation, Boston VA Research Institute, Regeneron Pharmaceuticals, Ironwood Pharmaceuticals, Incorporated, Amarin Corporation, Medicines Company, Kowa Company, Luitpold Pharmaceuticals, Singulex, Regado Biosciences, Belvoir Media Group, European Commission, Daiichi-Sankyo, Eisai, Novo Nordisk, Vifor Pharma, Idorsia Pharmaceuticals, National Institutes of Health, St. Jude Medical, Relypsa, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences, Duke Clinical Research Institute
Awards: G1717162763, The Harvard Clinical and Translational Science Center, G3029506724, G4463822314, G4880724714, G6355960561, G7199114025, G8909023964, Research Training in CVD Epidemiology and Prevention, Yale Clinical and Translational Science Award, Training Grant in Cardiovascular Research
OpenAlex ID: W2923192703
FWCI: 4.085
Cites: 4
Cited by: 57
Related to: 10